News on ISG from BioPortfolio.com http://www.BioPortfolio.com Consolidated ISG news from BioPortfolio.com Wed, 10 Feb 2010 02:28:32 GMT en Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971338&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971338&THISHREF=http://c.moreover.com/click/here.pl%3fz2501813655%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971338&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971338&THISHREF=http://c.moreover.com/click/here.pl%3fz2501813655%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970046&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970046&THISHREF=http://c.moreover.com/click/here.pl%3fz2501142850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970046&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970046&THISHREF=http://c.moreover.com/click/here.pl%3fz2501142850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967558&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967558&THISHREF=http://c.moreover.com/click/here.pl%3fz2499792571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967558&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967558&THISHREF=http://c.moreover.com/click/here.pl%3fz2499792571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Dynavax Reports Positive Phase 1b Data For Chronic Hepatitis C Infection Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967425&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967425&THISHREF=http://c.moreover.com/click/here.pl%3fz2499714624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967425&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967425&THISHREF=http://c.moreover.com/click/here.pl%3fz2499714624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: DVAX.NASDAQ Profiles for January 26, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967301&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967301&THISHREF=http://c.moreover.com/click/here.pl%3fz2499586613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967301&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967301&THISHREF=http://c.moreover.com/click/here.pl%3fz2499586613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Dynavax Technologies Corporation (DVAX) Hepatitis C Drug Shows Promise in Phase 1 Trial; Shares Soarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966570&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966570&THISHREF=http://c.moreover.com/click/here.pl%3fz2499085055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966570&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966570&THISHREF=http://c.moreover.com/click/here.pl%3fz2499085055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965211&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965211&THISHREF=http://c.moreover.com/click/here.pl%3fz2498421102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965211&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ISG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965211&THISHREF=http://c.moreover.com/click/here.pl%3fz2498421102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: